ClinicalTrials.Veeva

Menu

Effects of the Low-level Laser Therapy on Functional Capacity of the Patients With Coronary Artery Bypass Surgery

F

Federal University of Health Science of Porto Alegre

Status

Unknown

Conditions

Cardiovascular Diseases

Treatments

Device: Sham Low-Level Laser Therapy (Sham LLLT)
Device: 6J Low-Level Laser Therapy (6J LLLT)

Study type

Interventional

Funder types

Other

Identifiers

NCT02688426
LLLT-CABG-2016/1

Details and patient eligibility

About

The low-level laser therapy (LLLT) has been used in many inflammatory disorders.

More recently the LLLT was associated with an improvement in the muscle strength, endurance and functional capacity.But, these effects were described only in health or athletic individuals. In this randomized and controlled clinical trails, the investigators will study the effects of LLLT on functional capacity of the patients with Coronary artery bypass surgery.

Full description

This study will be conducing in a large hospital that is reference in Coronary artery bypass surgery. 15 patients will be randomized for placebo or low-level laser therapy (LLLT). The functional capacity will be test by test six-minute walk test before and after de LLLT. Moreover the application of LBP or placebo will be followed by assessments of muscle damage and oxidative stress. One-week interval between the LLLT will gave to reduce the influence between the treatments.

Enrollment

15 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients in the postoperative period of elective CABG referred for cardiac rehabilitation, which are the 15th and 30th days after surgery without ischemic changes and / or complex arrhythmias on the electrocardiogram, between 40 and 75 years of age who have performed the first surgery.

Exclusion criteria

  • Patients with decompensated heart failure; presence of any comorbidity such as: unstable angina; associated neurological disease; moderate respiratory illness to severe pre-diagnosed by the attending physician; active infectious disease or fever; disabling peripheral vascular disease; unstable ventricular arrhythmias; diabetes mellitus; use of cardiac pacemaker, musculoskeletal disease that limits physical activity, patients with a BMI ≥30.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

15 participants in 2 patient groups

0J LLLT
Sham Comparator group
Description:
The sham treatment is performed in the same way as treatment with LBP, however, with the apparatus switched off
Treatment:
Device: 6J Low-Level Laser Therapy (6J LLLT)
Device: Sham Low-Level Laser Therapy (Sham LLLT)
6J LLLT
Experimental group
Description:
The Laser radiation will be made with 6J by spot.
Treatment:
Device: 6J Low-Level Laser Therapy (6J LLLT)
Device: Sham Low-Level Laser Therapy (Sham LLLT)

Trial contacts and locations

1

Loading...

Central trial contact

Rodrigo Plentz, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems